From: Chromatographic assay of recently approved co-formulation of Vonoprazan fumarate with low dose Aspirin: AGREE, Complex MoGAPI, and RGB 12-model assessments
Analyte
Retention time (Rt), min
Capacity factor (k′)
Selectivity (α)
Resolution (Rs)
Asymmetry (A)
Efficiency (plates/m)
Fumarate
1.85
2.08
1.52
4.51
0.99
3181.24
ASP
2.50
3.17
3.15
12.49
0.98
4056.96
VON
6.59
9.98
------
0.84
2802.89